Survival After Endovascular Aneurysm Sealing Compared With Endovascular Aneurysm Repair

Abstract

Introduction

Endovascular aneurysm sealing (EVAS) is a sac-filling device with a blunted systemic inflammatory response compared to conventional endovascular aneurysm repair (EVAR), with a suggested impact on all-cause mortality. This study compares mortality after both EVAS and EVAR.

Materials and Methods

This is a retrospective observational study including data from 2 centres, with ethical approval. Elective procedures on asymptomatic infrarenal aneurysms performed between January 2011 until April 2018 were enrolled. Laboratory values (serum creatinine, haemoglobin, white blood cell count, platelet count) were measured pre- and postoperatively and at 1 and 2 years, respectively. Mortality and cause of death were recorded during follow-up.

Results

A total of 564 patients were included (225 EVAS, 369 EVAR), after propensity score matching there were 207 patients in both groups. Baseline characteristics were similar, except for larger neck angulation and more pulmonary disease in the EVAR group. The median follow-up time was 49 (EVAS) and 44 (EVAR) months. No significant differences regarding creatinine and haemoglobin were observed. Preoperative white blood cell count was higher in the EVAR group (p=0.011), without significant differences during follow-up. Median platelet count was lower in the EVAR group preoperatively (p=0.001), but was significantly higher at 1 year follow-up (p=0.003). There were 43 deaths within the EVAS group (20.8%) and 52 within the EVAR group (25.1%) (p=0.293). Of these, 4 were aneurysm related (EVAS n=3, EVAR n=1; p=0.222) and 14 cardiovascular (EVAS n=6, EVAR n=8, p=0.845). For the EVAS cohort, survival was 95.5% at 1 year and 74.9% at 5 years. For the EVAR cohort, this was 93.3% at 1 year and 75.5% at 5 years. No significant differences were observed in causes of death.

Conclusion

This study showed comparable survival rates through 5 years between EVAS and EVAR with a tendency toward higher inflammatory response in the EVAR patients through the first 2 years.

Keywords

abdominal aortic aneurysm endovascular aneurysm sealing endovascular aneurysm repair survival

Get full access to this article

View all access options for this article.

References

van den Ham

Zeebregts

de Vries

JPPM

, et al. Abdominal aortic aneurysm repair using Nellix™ EndoVascular Aneurysm Sealing. Surg Technol Int. 2015;26:226–231.

Tsilimigras

Sigala

Karaolanis

, et al. Cytokines as biomarkers of inflammatory response after open versus endovascular repair of abdominal aortic aneurysms: a systematic review. Acta Pharmacol Sin. 2018;39:1164–1175.

Swartbol

Truedsson

Norgren

Adverse reactions during endovascular treatment of aortic aneurysms may be triggered by interleukin 6 release from the thrombotic content. J Vasc Surg. 1998;28:664–668.

Lee

Choi

Kim

EJ.

Volume of mural thrombus plays a role in the elevation of inflammatory markers after endovascular aortic repair. J Cardiothor Surg. 2018;13:27.

Kakisis

Moulakakis

Antonopoulos

, et al. Volume of new-onset thrombus is associated with the development of postimplantation syndrome after endovascular aneurysm repair. J Vasc Surg. 2014;60:1140–1145.

Moris

Kontos

Mantonakis

, et al. Concept of the aortic aneurysm repair-related surgical stress: a review of the literature. Int J Clin Exp Med. 2014;7:2402–2412.

Bown

Nicholson

Bell

, et al. Cytokines and inflammatory pathways in the pathogenesis of multiple organ failure following abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2001;22:485–495.

Arnaoutoglou

Kouvelos

Papa

, et al. Prospective evaluation of post-implantation inflammatory response after EVAR for AAA: influence on patients 30 day outcome. Eur J Vasc Endovasc Surg. 2015;49:175–183.

Ziegenfuss

Wanner

Grass

, et al. Mixed agonistic-antagonistic cytokine response in whole blood from patients undergoing abdominal aortic aneurysm repair. Intensive Care Med. 1999;25:279–287.

10.

Bown

Horsburgh

Nicholson

, et al. Cytokines, their genetic polymorphisms, and outcome after abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2004;28:274–280.

11.

Berg

Stroetges

Miller

, et al. A propensity score matched analysis of inflammatory response with endovascular aneurysm sealing vs endovascular aneurysm repair. J Endovasc Ther. 2017;24:670–674.

12.

O’Donnell

TFX

Carpenter

Lane

3rd , et al. Endovascular aneurysm sealing is associated with higher medium-term survival than traditional EVAR. Ann Vasc Surg. 2020;63:145–154.

13.

O’Donnell

TFX

Deery

Boitano

, et al. Aneurysm sac failure to regress after endovascular aneurysm repair is associated with lower long-term survival. J Vasc Surg. 2019;69:414–422.

14.

Stoner

Calligaro

Chaer

, et al. Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease. J Vasc Surg. 2016;64:e1–e21.